Finance

Investors Notified of Deadline in QuidelOrtho Corporation Class Action Lawsuit

Published May 17, 2024

Los Angeles announces an important reminder for investors from law firm Glancy Prongay & Murray LLP ("GPM"). The deadline for filing a lead plaintiff motion in the class action lawsuit against QuidelOrtho Corporation (QDEL) is drawing near, specifically June 11, 2024. This lawsuit encompasses individuals who acquired shares of QuidelOrtho, as the company faces allegations of having provided misleading business information to the public.

About QuidelOrtho Corporation

QuidelOrtho Corporation, operating under the ticker QDEL, is an innovative developer and producer of diagnostic testing solutions. Their diverse array covers various medical sectors including infectious disease, cardiology, thyroid, women's health, eye health, gastrointestinal disease, and toxicology. The global reach of QuidelOrtho, headquartered in the vibrant city of San Diego, California, indicates its significance within the healthcare and diagnostics industry.

The Class Action Context

Investors who are part of this class action are encouraged to become a lead plaintiff, which involves taking on a central role within the lawsuit. This follows allegations that QuidelOrtho might have issued business information that was unreliable or deceptive, thereby influencing the investment decisions of shareholders. Investing in the stock market requires transparency and trust, and the basis of this lawsuit is that QuidelOrtho may have violated that trust, potentially impacting its stock value and the decisions investors made based on the information provided.

Implications for Investors

Investors with stakes in QDEL should assess their position in light of this lawsuit and the upcoming deadline. The outcome of this legal action could have significant ramifications for investors and the market value of QuidelOrtho's securities. Proactive participation is key, and those affected by the circumstances should evaluate their legal options promptly. The lawsuit's lead plaintiff position is open to investors who have suffered substantial losses and is designed to represent shareholders' interests within the class action framework.

lawsuit, deadline, investment